COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell therapeutic company focused on developing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today that C. Randal Mills, Ph.D., President and CEO, is scheduled to present at the Fourth Annual Piper Jaffray Europe Conference in London, UK on Wednesday, June 24, 2009 at 9:00 a.m. BST (4:00 a.m. EDT).
